Multivariable analyses of NRM and OS
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| NRM | |||
| Delirium (day 100) | .023 | ||
| No | Reference | ||
| Yes | 1.66 | 1.09-2.52 | |
| Fall (day 100) | .026 | ||
| No | Reference | ||
| Yes | 2.14 | 1.16-3.95 | |
| HCT-CI | <.001 | ||
| 0-2 | Reference | ||
| ≥3 | 2.04 | 1.37-3.04 | |
| KPS | .054 | ||
| ≥90 | Reference | ||
| <90 | 1.45 | 0.99-2.12 | |
| OS | |||
| Fall (day 100) | .016 | ||
| No | Reference | ||
| Yes | 1.93 | 1.18-3.14 | |
| DRI, revised | <.001 | ||
| Low/intermediate | Reference | ||
| High/very high | 1.79 | 1.35-2.39 | |
| Recipient CMV | .004 | ||
| Negative | Reference | ||
| Positive | 1.48 | 1.13-1.93 |
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| NRM | |||
| Delirium (day 100) | .023 | ||
| No | Reference | ||
| Yes | 1.66 | 1.09-2.52 | |
| Fall (day 100) | .026 | ||
| No | Reference | ||
| Yes | 2.14 | 1.16-3.95 | |
| HCT-CI | <.001 | ||
| 0-2 | Reference | ||
| ≥3 | 2.04 | 1.37-3.04 | |
| KPS | .054 | ||
| ≥90 | Reference | ||
| <90 | 1.45 | 0.99-2.12 | |
| OS | |||
| Fall (day 100) | .016 | ||
| No | Reference | ||
| Yes | 1.93 | 1.18-3.14 | |
| DRI, revised | <.001 | ||
| Low/intermediate | Reference | ||
| High/very high | 1.79 | 1.35-2.39 | |
| Recipient CMV | .004 | ||
| Negative | Reference | ||
| Positive | 1.48 | 1.13-1.93 |
Landmark analyses at day 100.